SEC Form 4 · accession 0001094891-15-000020
Origo Acquisition Corp · OACQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Lindsay A Rosenwald M.D.
Officer — Co-Chairman and CEO · Director · 10% Owner
CORONADO BIOSCIENCES INC
10% Owner
Period of report
Jan 5, 2015
Accepted (ET)
Jan 6, 2015 · 9:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001619551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jan 5, 2015 | J | 100,000 | $0.00 | D | 1,285,000 | I | By Coronado Biosciences, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1100,000 shares were compulsorily repurchased by the Issuer, for an aggregate purchase price of $0.01, in connection with the partial exercise by the underwriters of the over-allotment option, as described in the Issuer's registration statement on Form S-1.
- F2Mr. Rosenwald is the Chairman, President and Chief Executive Officer of Coronado Biosciences, Inc., and as such, controls the voting and disposition of such shares. Mr. Rosenwald disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that Mr. Rosenwald is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.